NasdaqCM - Nasdaq Real Time Price USD
Greenwich LifeSciences, Inc. (GLSI)
9.51
-0.15
(-1.60%)
As of 2:23:26 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.2 | -0.21 | -0.21 |
| EPS Actual | -0.19 | -0.2 | -0.2 | -0.61 |
| Difference | 0.01 | 0 | 0.01 | -0.4 |
| Surprise % | 5.00% | 0.00% | 4.76% | -190.48% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GLSI | -- | -- | -- | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/11/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/20/2024 |
Related Tickers
LYEL Lyell Immunopharma, Inc.
0.4077
-4.74%
SLS SELLAS Life Sciences Group, Inc.
1.5900
-5.36%
XBIO Xenetic Biosciences, Inc.
3.0100
-4.50%
CELZ Creative Medical Technology Holdings, Inc.
2.0668
-0.63%
ADVM Adverum Biotechnologies, Inc.
2.9200
-6.41%
1244.HK 3D MEDICINES
3.020
-3.51%
TARA Protara Therapeutics, Inc.
3.2483
-3.61%
DSGN Design Therapeutics, Inc.
3.4700
-1.42%
VERU Veru Inc.
0.5160
-1.16%
VTVT vTv Therapeutics Inc.
21.44
+0.89%